User banner image
User avatar
  • admin

Posts

Resonance Consultancy unveils the first-ever 2025 Asia-Pacific’s Best Cities Report

The global place branding advisor today announced the Asia-Pacific region’s 100 top-performing cities in their inaugural Asia-Pacific’s Best Cities Report, developed in partnership with Ipsos....

Assessment of the Natural and Organic Skin Care Products Industry 2025-2030, Featuring Analysis of 89 Major Companies

Technological Innovations in Natural Skin Care for Enhanced Moisturization and Hydration Driving Adoption Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) — The “Natural and Organic Skin...

Skincare Devices Market and Competition Analysis 2025-2030, Featuring 42 Major Companies Including Alma Lasers, Bausch Health Companies, Lumenis, Merz Pharma & More

Technological Advancements in Microcurrent and Radiofrequency Devices Propel Market Growth Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) — The “Skincare Devices – Global Strategic Business Report”...

Nail Care Market Trends and Regional Growth Opportunities, 2025-2030 – Rising Use of UV LED Nail Dryers Sets the Stage for Market Expansion

Gain insights into the U.S. market, valued at $2.9 Billion in 2024, and China, forecasted to grow at an impressive 4.6% CAGR to reach $2.7...

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of...

Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting

Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and water submersion New findings demonstrate dosing of...

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 nicotinic acetylcholine receptor positive allosteric modulator...

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

– Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 – –...

INmune Bio Opens Phase II in High Dose Cohort of INKmune™ Trial in Prostate Cancer

Medical review of Phase 1 cohorts demonstrated no safety issues Data to be presented at the 10th Annual Innate Killer Summit, March 3-5 BOCA RATON,...

Daqo New Energy to Announce Unaudited Results for the Fourth Quarter and Fiscal Year 2024 on February 27, 2025

SHANGHAI, Feb. 12, 2025 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy” or the “Company”), a leading manufacturer of high-purity polysilicon for...